Mafalda Ingenito

Mafalda Ingenito

Auto-generated profile, based on publicly available information

Mafalda Ingenito

University of Salerno

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2025
Verified
Conference Paper
Open access
LRLuigia Rizzo
Luigia Rizzo
DRDomenico Rossi
Domenico Rossi
MIMafalda Ingenito
Mafalda Ingenito
GTGenoveffa Tortora
Genoveffa Tortora

6 October 2025
Verified
Conference Paper
Open access
SMSaeedeh Mosaferchi
Saeedeh Mosaferchi
MIMafalda Ingenito
Mafalda Ingenito
Giuliana VitielloGiuliana Vitiello
Giuliana Vitiello
AMAlireza Mortezapour
Alireza Mortezapour
Alessandro NaddeoAlessandro Naddeo
Alessandro Naddeo



28 July 2026 in Multimedia Tools and Applications
Verified
Journal Article
Open access
PDF file
MIMafalda Ingenito
Mafalda Ingenito
OSOtino Pio Santosuosso
Otino Pio Santosuosso
Diabetic Retinopathy (DR) is a major cause of vision loss in diabetic patients, highlighting the need for predictive models of its progression. While deep learning has improved DR detection and grading, temporal and spatial prediction remain underexplored. We propose REMEDI, a multimodal deep learning framework that predicts both clinical evolution and spatial distribution of retinal lesions over time. Using clinical variables (BCVA, DRSS, CST) and the current lesion mask, REMEDI generates the predicted segmentation mask for the next visit, explicitly modeling temporal dynamics of clinical and spatial features. The framework jointly performs three tasks: (i) regression of clinical variables; (ii) prediction of lesion geometry evolution; and (iii) generation of follow-up lesion masks. These modalities are hierarchically integrated: clinical and morphological regression outputs, together with the baseline fundus mask, are used to inform the generation of the disease mask at the follow-up visit, capturing how the treatment is influencing the lesion progression. Results show that the LSTM and MLP models yield the most accurate clinical and morphometric predictions, while standard U-Net and Attention U-Net outperform more complex architectures in temporally consistent segmentation. REMEDI provides temporally consistent and interpretable forecasts, supporting personalized DR monitoring and treatment planning.

12 September 2025
Verified
Book Chapter
Closed access
PDF file
ACAndrea Antonio Cantone
Andrea Antonio Cantone
MIMafalda Ingenito
Mafalda Ingenito
SOSerena Matarazzo Orilia
Serena Matarazzo Orilia
OROrlando Ricciardi
Orlando Ricciardi
Giuliana VitielloGiuliana Vitiello
Giuliana Vitiello